140D042590015
Other Transaction Agreement
Overview
Government Description
GENE WRITER GENOME ENGINEERING FOR IN VIVO CAR-T
Awardee
Awarding Agency
Funding Agency
NAICS
Not Reported
Place of Performance
Somerville, MA 2143 United States
Pricing
Other
Set Aside
None
Extent Competed
Competed
Related Opportunity
None
Tessera Therapeutics was awarded
Other Transaction Agreement 140D042590015 140D042590015
for Gene Writer Genome Engineering For In Vivo Car-T
worth up to $41,342,707
by the National Institutes of Health
in September 2025.
The contract
has a duration of 6 years and
was awarded
full & open
with
PSC AN13
via program solicitation acquisition procedures.
As of today, the Other Transaction Agreement has a total reported backlog of $29,451,459.
Status
(Open)
Last Modified 9/25/25
Period of Performance
9/23/25
Start Date
9/22/27
Current End Date
9/22/31
Potential End Date
Obligations and Backlog
$11.9M
Total Obligated
$11.9M
Current Award
$41.3M
Potential Award
$0.0
Funded Backlog
$29.5M
Total Backlog
Award Hierarchy
Other Transaction Agreement
140D042590015
Subcontracts
OTA Details
Type of Agreement
Prototype
Non-Governmental Funding
None Reported
Non-Traditional Participation
Non-Traditional Significant Participation
Activity Timeline
People
Suggested agency contacts for 140D042590015
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Program Solicitation
Evaluated Preference
None
Commercial Item Acquisition
None
Simplified Procedures for Commercial Items
None
Other Categorizations
Subcontracting Plan
Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
XFPJKGA6ARL1
Awardee CAGE
9WU32
Agency Detail
Awarding Office
140D04 IBC ACQ SVCS DIRECTORATE (00004)
Funding Office
75N992
Created By
decarloj
Last Modified By
decarloj
Approved By
decarloj
Legislative
Legislative Mandates
None Applicable
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Representative
Ayanna Pressley
Modified: 9/25/25